SEARCH

SEARCH BY CITATION

References

  • 1
    Heit JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 2008; 28: 3702.
  • 2
    Ageno W, Dentali F. Venous thromboembolism and arterial thromboembolism. Many similarities, far beyond thrombosis per se. Thromb Haemost 2008; 100: 1813.
  • 3
    Prandoni P. Venous and arterial thrombosis: two aspects of the same disease? Clin Epidemiol 2009; 1: 116.
  • 4
    Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW, Prins MH, Girolami A. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003; 348: 143541.
  • 5
    Lowe GD. Is venous thrombosis a risk factor for arterial thrombosis? Lancet 2007; 370: 17424.
  • 6
    Sørensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 2007; 370: 17739.
  • 7
    Thrift AG, Dewey HM, Sturm JW, Srikanth VK, Gilligan AK, Gall SL, Macdonell RA, McNeil JJ, Donnan GA. Incidence of stroke subtypes in the North East Melbourne Stroke Incidence Study (NEMESIS): differences between men and women. Neuroepidemiology 2009; 32: 118.
  • 8
    Feigin VL, Lawes CM, Algra A, Bennett DA, van Gijn J, Anderson CS. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 2005; 36: 277380.
  • 9
    Ray WZ, Strom RG, Blackburn SL, Ashley WW, Sicard GA, Rich KM. Incidence of deep venous thrombosis after subarachnoid hemorrhage. J Neurosurg 2009; 110: 10104.
  • 10
    Peck G, Smeeth L, Whittaker J, Casas JP, Hingorani A, Sharma P. The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults. PLoS ONE 2008; 3: e3691.
  • 11
    Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol 2005; 162: 97582.
  • 12
    Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 2008; 117: 93102.
  • 13
    Kyrle PA, Eichinger S. Deep vein thrombosis. Lancet 2005; 365: 116374.
  • 14
    Goldhaber SZ. Pulmonary embolism. Lancet 2004; 363: 1295305.
  • 15
    Sandvei MS, Romundstad PR, Müller TB, Vatten L, Vik A. Risk factors for aneurysmal subarachnoid hemorrhage in a prospective population study: the HUNT study in Norway. Stroke 2009; 40: 195862.
  • 16
    Rinkel GJ, Djibuti M, Algra A, van Gijn J. Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 1998; 29: 2516.
  • 17
    Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH. The Danish National Hospital Register. Dan Med Bull 1999; 46: 2638.
  • 18
    Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006; 53: 4419.
  • 19
    Frank L. Epidemiology. When an entire country is a cohort. Science 2000; 287: 23989.
  • 20
    Gaist D, Vaeth M, Tsiropoulos I, Christensen K, Corder E, Olsen J, Sørensen HT. Risk of subarachnoid haemorrhage in first degree relatives of patients with subarachnoid haemorrhage: follow up study based on national registries in Denmark. BMJ 2000; 320: 1415.
  • 21
    Pomp ER, Rosendaal FR, Doggen CJ. Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. Am J Hematol 2008; 83: 97102.
  • 22
    Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med 2003; 139: 893900.
  • 23
    Carlsen J. Pulmonal hypertension, cor pulmonale og lungeemboli. In: Muckadel OS, Haunsø S, Vilstrup H, eds. Medicinsk Kompendium, 17 edn. Copenhagen: Nyt Nordisk Forlag, 2009: 118091.
  • 24
    Olsen M, Johansen MB, Christensen S, Sørensen HT. Use of oral anticoagulants and risk of subarachnoid haemorrhage: A population based case-control study. Eur J Intern Med 2010; 21: 297300.
  • 25
    Zhang B, Fugleholm K, Day LB, Ye S, Weller RO, Day IN. Molecular pathogenesis of subarachnoid haemorrhage. Int J Biochem Cell Biol 2003; 35: 134160.
  • 26
    Rosendaal FR, Reitsma PH. Genetics of venous thrombosis. J Thromb Haemost 2009; 1: 3014.
  • 27
    Ruigrok YM, Rinkel GJ, Wijmenga C. Genetics of intracranial aneurysms. Lancet Neurol 2005; 4: 17989.
  • 28
    Bor AS, Rinkel GJ, Adami J, Koffijberg H, Ekbom A, Buskens E, Blomqvist P, Granath F. Risk of subarachnoid haemorrhage according to number of affected relatives: a population based case-control study. Brain 2008; 131: 26625.
  • 29
    Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Ridker PM. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 2009; 360: 185161.
  • 30
    Wolfrum S, Jensen KS, Liao JK. Endothelium-dependent effects of statins. Arterioscler Thromb Vasc Biol 2003; 23: 72936.
  • 31
    Sørensen HT, Horvath-Puho E, Søgaard KK, Christensen S, Johnsen SP, Thomsen RW, Prandoni P, Baron JA. Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost 2009; 7: 5218.
  • 32
    Risselada R, Straatman H, van Kooten F, Dippel DW, van der Lugt A, Niessen WJ, Firouzian A, Herings RM, Sturkenboom MC. Withdrawal of statins and risk of subarachnoid hemorrhage. Stroke 2009; 40: 288792.
  • 33
    Ray JG. Do we care if statins prevent venous thromboembolism? J Thromb Haemost 2004; 2: 6956.
  • 34
    Undas A, Brummel-Ziedins KE, Mann KG. Statins and blood coagulation. Arterioscler Thromb Vasc Biol 2005; 25: 28794.
  • 35
    Squizzato A, Romualdi E, Ageno W. Why should statins prevent venous thromboembolism? A systematic literature search and a call for action. J Thromb Haemost 2006; 4: 19257.
  • 36
    Landmesser U, Bahlmann F, Mueller M, Spiekermann S, Kirchhoff N, Schulz S, Manes C, Fischer D, de Groot K, Fliser D, Fauler G, März W, Drexler H. Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans. Circulation 2005; 111: 235663.
  • 37
    Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994; 154: 8616.
  • 38
    Schulman S, Lindmarker P. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial. N Engl J Med 2000; 342: 19538.
  • 39
    Severinsen MT, Kristensen SR, Overvad K, Dethlefsen C, Tjønneland A, Johnsen SP. Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol 2010; 63: 2238.
  • 40
    Ingeman A, Pedersen L, Hundborg HH, Petersen P, Zielke S, Mainz J, Bartels P, Johnsen SP. Quality of care and mortality among patients with stroke: a nationwide follow-up study. Med Care 2008; 46: 639.
  • 41
    Johnsen SP, Pedersen L, Friis S, Blot WJ, McLaughlin JK, Olsen JH, Sørensen HT. Nonaspirin nonsteroidal anti-inflammatory drugs and risk of hospitalization for intracerebral hemorrhage: a population-based case-control study. Stroke 2003; 34: 38791.
  • 42
    Sørensen HT. Regional administrative health registers as a resource in clinical epidemiology. A study of options, strengths, limitations and data quality provided with examples of use. Int J Risk Saf Med 1997; 10: 122.